1. Munjal B, Koradia V, Boddu S, et al. Role of innovator product characterization in generic product development. In: Narang A, Boddu SHS, editors., et al., Excipient applications in formulation design and drug delivery. Cham: Springer; 2015.
2. Association for accessible medicines. Generic drug access and savings in the U.S. 2019. https://accessiblemeds.org/resources/reports/2018-generic-drug-access-andsavings-report;2018. Accessed 22 June 2021.
3. Soomaroo S. The department of trade and industry’s involvement in the state’s procurement of ARVs. In: Presented at the meeting of the portfolio committee on economic development, Pretoria, South Africa. 2017. https://www.thedti.gov.za/parliament/2017/Pharmaceuticals.pdf. Accessed 23 July 2021.
4. European medicines agency. Guideline on the investigation of bioequivalence by Committee for Medicinal Products for Human Use (CHMP), 20 Jan 2010. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf. Accessed 16 June 2021.
5. South African Health Products Health Authority (SAHPRA). Biostudies guideline, Version 6. June 2015. https://www.sahpra.org.za/wpcontent/uploads/2020/01/61de452d2.06_Biostudies_Jun15_v6.pdf. Accessed 18 June 2021.